Pharma Review: Trust Issues, Tablets, and One Very Guilty Medical Rep
Release Date : 19 Dec 2025
If you’ve ever swallowed a pill without reading the fine print (so… everyone), Pharma is here to politely—and then aggressively—make you uncomfortable.
Director: P. R. Arun
Cast: Nivin Pauly, Rajit Kapur, Narain, Shruti Ramachandran, Veena Nandakumar
Episodes: 8
Platform: Jio Hotstar
This Malayalam web series stars Nivin Pauly as KP Vinod, a wide-eyed, eternally hopeful medical representative whose biggest achievement at the start of the show is surviving his boss’s motivational speeches. KP wants success, validation, and maybe a little respect. What he gets instead is Kydoxin—a miracle drug that turns his career around and his conscience upside down. Because, of course, miracles always come with side effects.
Directed and written by P. R. Arun, Pharma begins like a workplace dramedy with good vibes and sharper sarcasm. Nivin Pauly eases into familiar territory—the lovable underdog with ambition—and the early episodes lean into humour and realism. Binu Pappu, as KP’s boss Alex, nearly steals the show with his corporate swagger and casually cruel pep talks, the kind of nightmare any pharma sales rep would recognize.
Then the series does what all good thrillers do: it yanks the rug out from under its hero. Once KP realises what Kydoxin is actually doing to patients, the tone shifts from “career goals” to “existential crisis.” Enter RLX, the pharmaceutical giant with enough money, lawyers, and moral flexibility to ruin several lifetimes. KP teams up with an NGO called Zaathi, led by the calm-but-dangerous Dr. Rajiv Rao (Rajit Kapur) and the ethically unshakeable Dr. Janaki (Shruti Ramachandran). Together, they decide to poke the corporate beast—and spoiler alert: it bites hard.
Pharma doesn’t pretend to be morally grey. This is a world where corporations are bad, whistleblowers are brave, and KP is the only one allowed a redemption arc. That simplicity works in the show’s favor when it focuses on its core idea: the medicine you trust could be harming you, and nobody’s really checking. A casually delivered line about “treating side effects with more medicines” is scarier than any background score, and the show’s emphasis on children as victims lands an emotional punch that’s hard to ignore.
That said, Pharma isn’t exactly a rollercoaster. Marketed as a medical thriller, it prefers a steady walk over a sprint. Twists are few, villains are more bureaucratic than diabolical, and much of the corporate evil remains theoretical rather than visceral. RLX mostly exists as an idea—an evil spreadsheet, if you will. The eight-episode format (each under 30 minutes) also feels restrictive. Just when things start heating up, the episode ends, leaving viewers wishing the show had either committed to being tighter or gone deeper.
Performance-wise, Nivin Pauly is solid and sincere, navigating KP’s evolution from overenthusiastic salesman to guilt-ridden crusader with ease. Shruti Ramachandran brings warmth and resolve to Dr. Janaki, making her one of the show’s emotional anchors. Rajit Kapur adds gravitas and credibility, proving once again that calm authority can be more effective than loud outrage. The supporting cast does what it can, though a few performances feel undercooked.
In the end, Pharma isn’t here to thrill you senseless—it’s here to make you think twice before popping your next pill. It may follow a familiar template and stumble in execution, but its intentions are sincere, and its message timely. Consider Pharma less a high-octane thriller and more a public service announcement with better acting and fewer disclaimers. Slightly flawed, mildly preachy, but undeniably relevant—and sometimes, that’s exactly what the doctor ordered.